Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

浙江海昶生物医药技术有限公司

Home Clinical Trial Sponsors and Organizations浙江海昶生物医药技术有限公司

浙江海昶生物医药技术有限公司

浙江省杭州市钱塘区下沙街道万晶湖畔中心西区2幢1109室, 杭州市, 浙江省www.zhejianghaichang.comEstablished: 2013-10-250571-26262022 xyq@zhejianghaichang.com

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

2

0 active

Approvals

1

Total approvals

Agencies

1

Regulatory bodies

Founded

2013

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

1

50.0%

Phase 1/2

1

50.0%

Trial Status Distribution

Recruiting

2

100.0%

Clinical Trials

Trials sponsored by this organization (2)

HC016脂质复合物注射液（HC016-DP）在晚期或复发性实体瘤患者中的安全性、耐受性、药代动力学、药效学和初步有效性的I期临床研究

WGI-0301单药以及联合索拉非尼在晚期肝细胞癌患者中的安全性、耐受性、药代动力学、药效学和有效性的多中心、开放标签I/II期临床研究

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

1

Approvals

Recent Approvals

Paclitaxel for Injection ( Albumin Bound)

News

No news articles found

On this page

Overview
Clinical Trials2
Approvals1
News

Back to Organizations